VOCLAZIDE 60 MR

VOCLAZIDE 60 MR TAB by Voithea Healthcare is an effective anti-diabetic formulation featuring Gliclazide 60mg in a Modified Release (MR) tablet, designed to offer sustained blood sugar control throughout the day. Gliclazide, a sulfonylurea class drug, stimulates insulin secretion from pancreatic β-cells, thereby helping to manage blood glucose levels in patients with type 2 diabetes.

The modified-release technology ensures consistent therapeutic action with reduced risk of hypoglycemia, making it a reliable choice for long-term diabetes management. VOCLAZIDE 60 MR TAB represents Voithea Healthcare’s dedication to providing advanced, patient-friendly diabetes care that aligns with modern treatment protocols.